Teladoc Health (TDOC) Competitors $10.06 -0.08 (-0.76%) As of 01/24/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TDOC vs. HIMS, OPCH, GH, RDNT, SHC, BTSG, VCYT, LFST, CON, and PRVAShould you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Teladoc Health vs. Hims & Hers Health Option Care Health Guardant Health RadNet Sotera Health BrightSpring Health Services Veracyte LifeStance Health Group Concentra Group Holdings Parent Privia Health Group Teladoc Health (NYSE:TDOC) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation. Which has more volatility & risk, TDOC or HIMS? Teladoc Health has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Does the media refer more to TDOC or HIMS? In the previous week, Hims & Hers Health had 15 more articles in the media than Teladoc Health. MarketBeat recorded 26 mentions for Hims & Hers Health and 11 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.45 beat Hims & Hers Health's score of 0.45 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 12 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in TDOC or HIMS? Teladoc Health received 639 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 63.02% of users gave Teladoc Health an outperform vote while only 39.05% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformTeladoc HealthOutperform Votes68063.02% Underperform Votes39936.98% Hims & Hers HealthOutperform Votes4139.05% Underperform Votes6460.95% Which has stronger earnings & valuation, TDOC or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeladoc Health$2.60B0.67-$220.37M-$5.77-1.74Hims & Hers Health$872M7.74-$23.55M$0.4470.20 Do analysts rate TDOC or HIMS? Teladoc Health presently has a consensus price target of $12.08, suggesting a potential upside of 20.03%. Hims & Hers Health has a consensus price target of $25.13, suggesting a potential downside of 18.63%. Given Teladoc Health's higher probable upside, research analysts plainly believe Teladoc Health is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teladoc Health 0 Sell rating(s) 14 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.33Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.35 Do insiders & institutionals have more ownership in TDOC or HIMS? 76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 1.0% of Teladoc Health shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is TDOC or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Teladoc Health's net margin of -37.91%. Hims & Hers Health's return on equity of 10.97% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Teladoc Health-37.91% -10.06% -4.86% Hims & Hers Health 8.19%10.97%8.29% SummaryHims & Hers Health beats Teladoc Health on 11 of the 17 factors compared between the two stocks. Get Teladoc Health News Delivered to You Automatically Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TDOC vs. The Competition Export to ExcelMetricTeladoc HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$1.70B$1.11B$5.46B$20.09BDividend YieldN/AN/A5.35%3.62%P/E RatioN/A7.8061.8135.57Price / Sales0.671.781,231.5417.89Price / Cash12.1838.7544.3720.35Price / Book0.728.465.085.78Net Income-$220.37M-$52.07M$117.95M$1.01B7 Day Performance10.64%6.29%3.12%1.58%1 Month Performance5.59%20.43%2.65%4.23%1 Year Performance-50.20%-0.64%30.21%18.07% Teladoc Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TDOCTeladoc Health2.5442 of 5 stars$10.06-0.8%$12.08+20.0%-50.6%$1.70B$2.60B-1.745,600Analyst ForecastOptions VolumeNews CoverageHIMSHims & Hers Health3.1814 of 5 stars$27.80-0.5%$25.13-9.6%+239.8%$6.07B$872M63.191,046Insider TradeNews CoverageOPCHOption Care Health4.783 of 5 stars$29.16-0.5%$29.86+2.4%-3.2%$4.96B$4.30B24.507,802Analyst UpgradeNews CoveragePositive NewsGHGuardant Health3.9538 of 5 stars$36.66-1.7%$40.60+10.7%+108.7%$4.53B$563.95M-8.651,779Analyst ForecastAnalyst RevisionNews CoverageRDNTRadNet3.5246 of 5 stars$59.86-1.7%$79.75+33.2%+73.5%$4.43B$1.62B-855.0210,288Analyst ForecastNews CoverageSHCSotera Health3.2481 of 5 stars$12.98+2.3%$16.08+23.9%-8.6%$3.68B$1.05B51.923,000BTSGBrightSpring Health Services2.1625 of 5 stars$18.55+0.4%$18.65+0.6%N/A$3.23B$8.83B-71.3535,000VCYTVeracyte4.0615 of 5 stars$40.58-1.3%$41.13+1.3%+68.4%$3.14B$361.05M-270.53790News CoveragePositive NewsHigh Trading VolumeLFSTLifeStance Health Group1.2758 of 5 stars$7.99+0.1%$8.70+8.9%+23.0%$3.06B$1.06B-30.739,325Positive NewsCONConcentra Group Holdings ParentN/A$21.17+0.7%$28.50+34.6%N/A$2.70B$1.88B0.0011,000Analyst ForecastLockup ExpirationNews CoveragePRVAPrivia Health Group3.5017 of 5 stars$22.24+1.8%$24.88+11.9%-0.7%$2.67B$1.66B222.421,102News Coverage Related Companies and Tools Related Companies HIMS Alternatives OPCH Alternatives GH Alternatives RDNT Alternatives SHC Alternatives BTSG Alternatives VCYT Alternatives LFST Alternatives CON Alternatives PRVA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:TDOC) was last updated on 1/26/2025 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teladoc Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teladoc Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
